The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1725
March 31, 2025
View Complete Issue         Table of Contents 2019 
Treatment of Allergic Rhinitis and Allergic Conjunctivitis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Treatment of Allergic Rhinitis and Allergic Conjunctivitis
March 31, 2025 (Issue: 1725)
Initial treatment of allergic rhinitis (AR) depends on the severity of symptoms and whether they are intermittent or persistent (see Table 1).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Treatment of Allergic Rhinitis and Allergic Conjunctivitis
Article code: 1725a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.